<VariationArchive VariationID="2674008" VariationName="NM_000143.4(FH):c.233dup (p.Asn78fs)" VariationType="Duplication" Accession="VCV002674008" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-15" DateCreated="2023-12-25" MostRecentSubmission="2023-12-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2841500" VariationID="2674008">
      <GeneList>
        <Gene Symbol="FH" FullName="fumarate hydratase" GeneID="2271" HGNC_ID="HGNC:3700" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q43</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="241497603" stop="241519755" display_start="241497603" display_stop="241519755" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="241660856" stop="241683084" display_start="241660856" display_stop="241683084" Strand="-" />
          </Location>
          <OMIM>136850</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FH">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FH">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000143.4(FH):c.233dup (p.Asn78fs)</Name>
      <CanonicalSPDI>NC_000001.11:241517215:TT:TTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1q43</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="241517215" stop="241517216" display_start="241517215" display_stop="241517216" variantLength="1" positionVCF="241517215" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="241680515" stop="241680516" display_start="241680515" display_stop="241680516" variantLength="1" positionVCF="241680515" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
      </Location>
      <ProteinChange>N78fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.241680517dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.241680517dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.241517217dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.241517217dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012338.1" sequenceAccession="NG_012338" sequenceVersion="1" change="g.7539dup">
            <Expression>NG_012338.1:g.7539dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000143.4" sequenceAccession="NM_000143" sequenceVersion="4" change="c.233dup" MANESelect="true">
            <Expression>NM_000143.4:c.233dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000134.2" sequenceAccession="NP_000134" sequenceVersion="2" change="p.Asn78fs">
            <Expression>NP_000134.2:p.Asn78fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_504" sequenceAccession="LRG_504">
            <Expression>LRG_504:g.7539dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_504t1" sequenceAccession="LRG_504t1">
            <Expression>LRG_504t1:c.232dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_504p1" sequenceAccession="LRG_504p1" change="p.Asn78Lysfs">
            <Expression>LRG_504p1:p.Asn78Lysfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000143.4(FH):c.233dup (p.Asn78fs) AND Hereditary leiomyomatosis and renal cell cancer" Accession="RCV003450609" Version="1">
        <ClassifiedConditionList TraitSetID="6363">
          <ClassifiedCondition DB="MedGen" ID="C1708350">Hereditary leiomyomatosis and renal cell cancer</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-12-25" MostRecentSubmission="2023-12-24">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="6363" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5392" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MULTIPLE CUTANEOUS AND UTERINE LEIOMYOMATA 1, WITH OR WITHOUT RENAL CELL CARCINOMA</ElementValue>
                <XRef Type="MIM" ID="150800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary leiomyomatosis and renal cell cancer</ElementValue>
                <XRef ID="Leiomyomatosis+and+renal+cell+cancer%2C+hereditary/4161" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007888" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Reed syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multiple cutaneous and uterine leiomyomatosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cutaneous leiomyomata with uterine leiomyomata</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leiomyoma, hereditary multiple, of skin</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multiple cutaneous and uterine leiomyomata</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leiomyoma, multiple cutaneous</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multiple cutaneous leiomyomas</ElementValue>
                <XRef ID="HP:0007437" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial leiomyomatosis</ElementValue>
                <XRef ID="MONDO:0023616" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HLRCC</ElementValue>
                <XRef Type="MIM" ID="150800" DB="OMIM" />
                <XRef Type="MIM" ID="605839" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LRCC</ElementValue>
                <XRef Type="MIM" ID="150800" DB="OMIM" />
                <XRef Type="MIM" ID="605839" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MCL</ElementValue>
                <XRef Type="MIM" ID="150800" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MCUL</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MCUL1</ElementValue>
                <XRef Type="MIM" ID="150800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000508575" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501397" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528532" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570011" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501539" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501395" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528534" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501538" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592488" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592450" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500895" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000595970" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000530028" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520030" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10096" />
                <XRef ID="10096" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3218" />
                <XRef ID="3218" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">FH tumor predisposition syndrome is characterized by cutaneous leiomyomata, uterine leiomyomata (fibroids), and/or renal tumors. Pheochromocytoma and paraganglioma have also been described in a small number of families. Cutaneous leiomyomata appear as skin-colored to light brown papules or nodules distributed over the trunk and extremities, and occasionally on the face, and appear at a mean age of 30 years, increasing in size and number with age. Uterine leiomyomata tend to be numerous and large; age at diagnosis ranges from 18 to 53 years, with most women experiencing irregular or heavy menstruation and pelvic pain. Renal tumors are usually unilateral, solitary, and aggressive. They are associated with poor survival due to clinical aggressiveness and propensity to metastasize despite small primary tumor size. The median age of detection is approximately age 40 years.</Attribute>
                <XRef ID="NBK1252" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301430</ID>
                <ID Source="BookShelf">NBK1252</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="KCRNC, 2013">
                <ID Source="PubMed">24319509</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Renal cell carcinoma genetics">
                <ID Source="PubMed">26389510</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, HLRCC syndrome">
                <URL>https://www.cancer.gov/types/kidney/hp/renal-cell-carcinoma-genetics/hlrcc-syndrome</URL>
                <CitationText>PDQÂ® Cancer Genetics Editorial Board. PDQ Hereditary Leiomyomatosis and Renal Cell Cancer. Bethesda, MD: National Cancer Institute. Updated &lt;03/08/2021&gt;. Accessed &lt;05/05/2021&gt;.</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="523" DB="Orphanet" />
              <XRef ID="C1708350" DB="MedGen" />
              <XRef ID="MONDO:0007888" DB="MONDO" />
              <XRef Type="MIM" ID="150800" DB="OMIM" />
              <XRef Type="primary" ID="HP:0007437" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7827986" SubmissionDate="2023-12-21" DateLastUpdated="2023-12-24" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="102505677|OMIM:150800" />
        <ClinVarAccession Accession="SCV004186016" DateUpdated="2023-12-24" DateCreated="2023-12-24" Type="SCV" Version="1" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8ufcwsf2/myriad_genetics_classification_criteria_2023.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="1" alternateAllele="GT" referenceAllele="G" start="241680515" stop="241680515" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">102505677</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="150800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14104645</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7827986" TraitType="Disease" MappingType="XRef" MappingValue="150800" MappingRef="OMIM">
        <MedGen CUI="C1708350" Name="Hereditary leiomyomatosis and renal cell cancer" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

